$SPRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GUIDED THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GUIDED THERAPEUTICS INC. Get notifications about new insider transactions in GUIDED THERAPEUTICS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 06 2012 | SPRX | GUIDED THERAPEUTIC ... | ALLEN RONALD W | Director | Option Exercise | A | 0.00 | 125,869 | 0 | 125,869 | |
Jul 06 2012 | SPRX | GUIDED THERAPEUTIC ... | ALLEN RONALD W | Director | Option Exercise | D | 0.65 | 242,535 | 157,648 | 0 | |
Jul 06 2012 | SPRX | GUIDED THERAPEUTIC ... | ALLEN RONALD W | Director | Buy | M | 0.40 | 125,869 | 50,348 | 250,210 | 124.3 K to 250.2 K (+101.23 %) |
May 25 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.75 | 3,900 | 2,906 | 538,368 | 542.3 K to 538.4 K (-0.72 %) |
May 25 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.76 | 2,500 | 1,888 | 542,268 | 544.8 K to 542.3 K (-0.46 %) |
May 25 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.76 | 6,100 | 4,612 | 544,768 | 550.9 K to 544.8 K (-1.11 %) |
May 18 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.76 | 2,500 | 1,898 | 550,868 | 553.4 K to 550.9 K (-0.45 %) |
May 18 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.76 | 2,900 | 2,204 | 553,368 | 556.3 K to 553.4 K (-0.52 %) |
May 18 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.77 | 2,500 | 1,923 | 556,268 | 558.8 K to 556.3 K (-0.45 %) |
May 18 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.78 | 4,600 | 3,588 | 558,768 | 563.4 K to 558.8 K (-0.82 %) |
May 15 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.83 | 12,500 | 10,375 | 563,368 | 575.9 K to 563.4 K (-2.17 %) |
May 02 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.80 | 7,100 | 5,680 | 575,868 | 583 K to 575.9 K (-1.22 %) |
May 02 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.83 | 5,400 | 4,482 | 582,968 | 588.4 K to 583 K (-0.92 %) |
Apr 24 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.83 | 4,600 | 3,818 | 588,368 | 593 K to 588.4 K (-0.78 %) |
Apr 24 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.84 | 2,500 | 2,088 | 592,968 | 595.5 K to 593 K (-0.42 %) |
Apr 24 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.84 | 5,400 | 4,536 | 595,468 | 600.9 K to 595.5 K (-0.90 %) |
Apr 23 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.85 | 7,500 | 6,338 | 600,868 | 608.4 K to 600.9 K (-1.23 %) |
Apr 23 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.85 | 5,000 | 4,250 | 608,368 | 613.4 K to 608.4 K (-0.82 %) |
Apr 19 2012 | SPRX | GUIDED THERAPEUTIC ... | ROSENSTOCK LINDA | Director | Option Exercise | A | 0.81 | 75,000 | 60,750 | 75,000 | |
Apr 18 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.83 | 2,500 | 2,075 | 613,368 | 615.9 K to 613.4 K (-0.41 %) |
Apr 18 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.84 | 4,700 | 3,943 | 615,868 | 620.6 K to 615.9 K (-0.76 %) |
Apr 18 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.85 | 1,000 | 850 | 620,568 | 621.6 K to 620.6 K (-0.16 %) |
Apr 18 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.86 | 4,300 | 3,698 | 621,568 | 625.9 K to 621.6 K (-0.69 %) |
Apr 02 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.90 | 12,500 | 11,250 | 625,868 | 638.4 K to 625.9 K (-1.96 %) |
Mar 29 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.89 | 12,500 | 11,125 | 638,368 | 650.9 K to 638.4 K (-1.92 %) |
Mar 20 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.96 | 12,500 | 12,000 | 650,868 | 663.4 K to 650.9 K (-1.88 %) |
Mar 19 2012 | SPRX | GUIDED THERAPEUTIC ... | Bambot Shabbir Bakir | V.P. R & D | Grant | A | 0.30 | 15,000 | 4,500 | 15,000 | 30 K to 15 K (-50.00 %) |
Mar 19 2012 | SPRX | GUIDED THERAPEUTIC ... | Bambot Shabbir Bakir | V.P. R & D | Sell | D | 1.00 | 15,000 | 15,000 | 0 | 15 K to 0 (-100.00 %) |
Mar 16 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.98 | 12,500 | 12,250 | 663,368 | 675.9 K to 663.4 K (-1.85 %) |
Mar 07 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.88 | 8,600 | 7,568 | 675,868 | 684.5 K to 675.9 K (-1.26 %) |
Mar 07 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.90 | 3,900 | 3,510 | 684,468 | 688.4 K to 684.5 K (-0.57 %) |
Mar 02 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.75 | 12,500 | 9,400 | 688,368 | 700.9 K to 688.4 K (-1.78 %) |
Feb 22 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.69 | 7,500 | 5,175 | 700,868 | 708.4 K to 700.9 K (-1.06 %) |
Feb 22 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.70 | 2,500 | 1,748 | 708,368 | 710.9 K to 708.4 K (-0.35 %) |
Feb 22 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.70 | 2,500 | 1,750 | 710,868 | 713.4 K to 710.9 K (-0.35 %) |
Feb 17 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.70 | 2,500 | 1,745 | 713,368 | 715.9 K to 713.4 K (-0.35 %) |
Feb 17 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.70 | 5,000 | 3,500 | 715,868 | 720.9 K to 715.9 K (-0.69 %) |
Feb 17 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.71 | 2,500 | 1,763 | 720,868 | 723.4 K to 720.9 K (-0.35 %) |
Feb 17 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.71 | 2,500 | 1,775 | 723,368 | 725.9 K to 723.4 K (-0.34 %) |
Feb 13 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.69 | 2,900 | 2,001 | 725,868 | 728.8 K to 725.9 K (-0.40 %) |
Feb 13 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.70 | 16,500 | 11,468 | 728,768 | 745.3 K to 728.8 K (-2.21 %) |
Feb 13 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.70 | 5,600 | 3,920 | 745,268 | 750.9 K to 745.3 K (-0.75 %) |
Jan 30 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.68 | 10,000 | 6,800 | 750,868 | 760.9 K to 750.9 K (-1.31 %) |
Jan 30 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.69 | 2,500 | 1,725 | 760,868 | 763.4 K to 760.9 K (-0.33 %) |
Jan 25 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 1.42 | 9,500 | 13,490 | 763,368 | 772.9 K to 763.4 K (-1.23 %) |
Jan 25 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 1.43 | 3,000 | 4,290 | 772,868 | 775.9 K to 772.9 K (-0.39 %) |
Jan 13 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 1.68 | 500 | 840 | 777,868 | 778.4 K to 777.9 K (-0.06 %) |
Jan 13 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 1.69 | 10,000 | 16,900 | 778,368 | 788.4 K to 778.4 K (-1.27 %) |
Jan 09 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 1.77 | 4,500 | 7,965 | 788,368 | 792.9 K to 788.4 K (-0.57 %) |
Jan 09 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 1.78 | 8,000 | 14,240 | 792,868 | 800.9 K to 792.9 K (-1.00 %) |
Jan 06 2012 | SPRX | GUIDED THERAPEUTIC ... | Bambot Shabbir Bakir | V.P. R & D | Grant | A | 0.30 | 7,500 | 2,250 | 7,500 | 15 K to 7.5 K (-50.00 %) |
Jan 06 2012 | SPRX | GUIDED THERAPEUTIC ... | Bambot Shabbir Bakir | V.P. R & D | Sell | D | 1.47 | 7,500 | 11,025 | 0 | 7.5 K to 0 (-100.00 %) |
Jan 03 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 1.40 | 6,648 | 9,307 | 800,868 | 807.5 K to 800.9 K (-0.82 %) |
Jan 03 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 1.42 | 4,142 | 5,882 | 807,516 | 811.7 K to 807.5 K (-0.51 %) |
Jan 03 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 1.45 | 1,710 | 2,480 | 811,658 | 813.4 K to 811.7 K (-0.21 %) |
Dec 28 2011 | SPRX | GUIDED THERAPEUTIC ... | FOWLER RICHARD | V.P. ENGINEERING | Option Exercise | A | 0.15 | 125,000 | 18,375 | 461,000 | |
Dec 28 2011 | SPRX | GUIDED THERAPEUTIC ... | FAUPEL MARK L | CEO & ACTING CFO | Option Exercise | A | 1.47 | 130,000 | 191,100 | 2,136,000 | |
Dec 28 2011 | SPRX | GUIDED THERAPEUTIC ... | Bambot Shabbir Bakir | V.P.R & D | Option Exercise | A | 1.47 | 120,000 | 176,400 | 757,500 | |
Dec 28 2011 | SPRX | GUIDED THERAPEUTIC ... | Bambot Shabbir Bakir | V.P.R & D | Grant | A | 0.24 | 5,000 | 1,200 | 22,500 | 27.5 K to 22.5 K (-18.18 %) |
Dec 28 2011 | SPRX | GUIDED THERAPEUTIC ... | Bambot Shabbir Bakir | V.P.R & D | Sell | D | 1.00 | 22,500 | 22,500 | 0 | 22.5 K to 0 (-100.00 %) |
Dec 22 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 1.50 | 10,000 | 15,000 | 813,368 | 823.4 K to 813.4 K (-1.21 %) |
Dec 22 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 1.50 | 1,800 | 2,700 | 823,368 | 825.2 K to 823.4 K (-0.22 %) |
Dec 22 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 1.47 | 700 | 1,029 | 825,168 | 825.9 K to 825.2 K (-0.08 %) |
Dec 02 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.93 | 3,700 | 3,441 | 850,868 | 854.6 K to 850.9 K (-0.43 %) |
Dec 02 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.95 | 8,800 | 8,360 | 854,568 | 863.4 K to 854.6 K (-1.02 %) |
Dec 14 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 1.34 | 2,071 | 2,775 | 825,868 | 827.9 K to 825.9 K (-0.25 %) |
Dec 14 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Buy | D | 1.33 | 6,379 | 8,484 | 827,939 | 821.6 K to 827.9 K (+0.78 %) |
Dec 14 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 1.32 | 2,500 | 3,300 | 834,318 | 836.8 K to 834.3 K (-0.30 %) |
Dec 14 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 1.30 | 1,550 | 2,015 | 836,818 | 838.4 K to 836.8 K (-0.18 %) |
Nov 28 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Option Exercise | M | 0.78 | 25,000 | 19,500 | 51,250 | |
Nov 28 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.94 | 10,000 | 9,400 | 863,368 | 873.4 K to 863.4 K (-1.14 %) |
Nov 28 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.94 | 2,500 | 2,350 | 873,368 | 875.9 K to 873.4 K (-0.29 %) |
Nov 28 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Buy | M | 0.00 | 37,500 | 0 | 63,750 | 26.3 K to 63.8 K (+142.86 %) |
Dec 06 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.96 | 12,500 | 12,000 | 838,368 | 850.9 K to 838.4 K (-1.47 %) |
Nov 10 2011 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Option Exercise | M | 0.08 | 200,000 | 15,600 | 222,500 | |
Nov 10 2011 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Option Exercise | M | 0.78 | 25,000 | 19,500 | 247,500 | |
Nov 10 2011 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Buy | M | 0.00 | 32,500 | 0 | 6,012,629 | 6 M to 6 M (+0.54 %) |
Nov 18 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.90 | 6,400 | 5,760 | 875,868 | 882.3 K to 875.9 K (-0.73 %) |
Nov 18 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.90 | 6,100 | 5,490 | 882,268 | 888.4 K to 882.3 K (-0.69 %) |
Nov 17 2011 | SPRX | GUIDED THERAPEUTIC ... | Niloff Jonathan M | Director | Option Exercise | M | 0.78 | 50,000 | 39,000 | 61,667 | |
Nov 17 2011 | SPRX | GUIDED THERAPEUTIC ... | Niloff Jonathan M | Director | Option Exercise | M | 0.78 | 25,000 | 19,500 | 86,667 | |
Nov 17 2011 | SPRX | GUIDED THERAPEUTIC ... | Niloff Jonathan M | Director | Buy | M | 0.00 | 27,500 | 0 | 39,167 | 11.7 K to 39.2 K (+235.71 %) |
Nov 10 2011 | SPRX | GUIDED THERAPEUTIC ... | ALLEN RONALD W | Director | Option Exercise | M | 0.78 | 75,000 | 58,500 | 617,500 | |
Nov 10 2011 | SPRX | GUIDED THERAPEUTIC ... | ALLEN RONALD W | Director | Option Exercise | M | 0.78 | 25,000 | 19,500 | 642,500 | |
Nov 10 2011 | SPRX | GUIDED THERAPEUTIC ... | ALLEN RONALD W | Director | Buy | M | 0.00 | 30,000 | 0 | 124,341 | 94.3 K to 124.3 K (+31.80 %) |
Nov 03 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.75 | 8,500 | 6,375 | 900,868 | 909.4 K to 900.9 K (-0.93 %) |
Nov 03 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.77 | 4,000 | 3,080 | 909,368 | 913.4 K to 909.4 K (-0.44 %) |
Nov 10 2011 | SPRX | GUIDED THERAPEUTIC ... | HART RONALD W | Director | Option Exercise | M | 0.78 | 50,000 | 39,000 | 425,000 | |
Nov 10 2011 | SPRX | GUIDED THERAPEUTIC ... | HART RONALD W | Director | Option Exercise | M | 0.78 | 25,000 | 19,500 | 450,000 | |
Nov 10 2011 | SPRX | GUIDED THERAPEUTIC ... | HART RONALD W | Director | Buy | M | 0.00 | 30,000 | 0 | 873,275 | 843.3 K to 873.3 K (+3.56 %) |
Nov 09 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.92 | 1,500 | 1,380 | 888,368 | 889.9 K to 888.4 K (-0.17 %) |
Nov 09 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.94 | 11,000 | 10,340 | 889,868 | 900.9 K to 889.9 K (-1.22 %) |
Nov 01 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.71 | 2,500 | 1,763 | 913,368 | 915.9 K to 913.4 K (-0.27 %) |
Nov 01 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.70 | 10,000 | 7,000 | 915,868 | 925.9 K to 915.9 K (-1.08 %) |
Oct 24 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.75 | 6,500 | 4,875 | 925,868 | 932.4 K to 925.9 K (-0.70 %) |
Oct 24 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.76 | 3,500 | 2,660 | 932,368 | 935.9 K to 932.4 K (-0.37 %) |
Oct 24 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.77 | 2,500 | 1,925 | 935,868 | 938.4 K to 935.9 K (-0.27 %) |
Oct 13 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.75 | 5,500 | 4,125 | 938,368 | 943.9 K to 938.4 K (-0.58 %) |
Oct 13 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.76 | 5,000 | 3,800 | 943,868 | 948.9 K to 943.9 K (-0.53 %) |
Oct 13 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.77 | 2,000 | 1,540 | 948,868 | 950.9 K to 948.9 K (-0.21 %) |
Oct 13 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.70 | 2,300 | 1,610 | 950,868 | 953.2 K to 950.9 K (-0.24 %) |
Oct 13 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.73 | 1,200 | 876 | 953,168 | 954.4 K to 953.2 K (-0.13 %) |
Oct 13 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.74 | 2,500 | 1,850 | 954,368 | 956.9 K to 954.4 K (-0.26 %) |
Oct 13 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.75 | 5,000 | 3,750 | 956,868 | 961.9 K to 956.9 K (-0.52 %) |
Oct 13 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.80 | 1,500 | 1,200 | 961,868 | 963.4 K to 961.9 K (-0.16 %) |
Oct 03 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.78 | 6,250 | 4,875 | 963,368 | 969.6 K to 963.4 K (-0.64 %) |
Oct 03 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.77 | 6,250 | 4,813 | 969,618 | 975.9 K to 969.6 K (-0.64 %) |
Sep 27 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.80 | 5,500 | 4,400 | 975,868 | 981.4 K to 975.9 K (-0.56 %) |
Sep 27 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.83 | 7,000 | 5,810 | 981,368 | 988.4 K to 981.4 K (-0.71 %) |
Sep 16 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.89 | 12,500 | 11,125 | 988,368 | 1 M to 988.4 K (-1.25 %) |
Sep 09 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.87 | 3,189 | 2,774 | 1,000,868 | 1 M to 1 M (-0.32 %) |
Sep 09 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.89 | 9,311 | 8,287 | 1,004,057 | 1 M to 1 M (-0.92 %) |
Sep 06 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.94 | 3,950 | 3,713 | 1,013,368 | 1 M to 1 M (-0.39 %) |
Sep 06 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.93 | 6,700 | 6,231 | 1,017,318 | 1 M to 1 M (-0.65 %) |
Sep 06 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.92 | 1,850 | 1,702 | 1,024,018 | 1 M to 1 M (-0.18 %) |
Aug 24 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.81 | 12,500 | 10,125 | 1,026 | 13.5 K to 1 K (-92.41 %) |
Aug 19 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.79 | 3,677 | 2,905 | 1,038,368 | 1 M to 1 M (-0.35 %) |
Aug 19 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.80 | 4,623 | 3,698 | 1,042,045 | 1 M to 1 M (-0.44 %) |
Aug 19 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.80 | 4,000 | 3,200 | 1,046,668 | 1.1 M to 1 M (-0.38 %) |
Aug 19 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.80 | 200 | 160 | 1,050,668 | 1.1 M to 1.1 M (-0.02 %) |
Aug 15 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.75 | 5,300 | 3,975 | 1,050,868 | 1.1 M to 1.1 M (-0.50 %) |
Aug 15 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.76 | 2,500 | 1,900 | 1,056,168 | 1.1 M to 1.1 M (-0.24 %) |
Aug 15 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.78 | 2,800 | 2,184 | 1,058,668 | 1.1 M to 1.1 M (-0.26 %) |
Aug 15 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.79 | 1,900 | 1,501 | 1,061,468 | 1.1 M to 1.1 M (-0.18 %) |
Aug 04 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.85 | 400 | 340 | 1,063,368 | 1.1 M to 1.1 M (-0.04 %) |
Aug 04 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.86 | 12,100 | 10,406 | 1,063,768 | 1.1 M to 1.1 M (-1.12 %) |
Jul 12 2011 | SPRX | GUIDED THERAPEUTIC ... | Bambot Shabbir Bakir | V.P. R & D | Grant | A | 0.30 | 5,000 | 1,500 | 15,399 | 20.4 K to 15.4 K (-24.51 %) |
Jul 12 2011 | SPRX | GUIDED THERAPEUTIC ... | Bambot Shabbir Bakir | V.P. R & D | Sell | D | 1.00 | 5,000 | 5,000 | 10,399 | 15.4 K to 10.4 K (-32.47 %) |
Aug 01 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.90 | 12,500 | 11,250 | 1,075,868 | 1.1 M to 1.1 M (-1.15 %) |
Jul 22 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.88 | 7,500 | 6,600 | 1,088,368 | 1.1 M to 1.1 M (-0.68 %) |
Jul 22 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.87 | 5,000 | 4,350 | 1,095,868 | 1.1 M to 1.1 M (-0.45 %) |
Jul 11 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.98 | 12,500 | 12,250 | 1,100,868 | 1.1 M to 1.1 M (-1.12 %) |
Jul 11 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.94 | 9,900 | 9,306 | 1,113,568 | 1.1 M to 1.1 M (-0.88 %) |
Jul 11 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.95 | 2,500 | 2,375 | 1,123,268 | 1.1 M to 1.1 M (-0.22 %) |
Jul 11 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 1.00 | 100 | 100 | 1,125,768 | 1.1 M to 1.1 M (-0.01 %) |
Jun 21 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.90 | 3,500 | 3,150 | 1,125,868 | 1.1 M to 1.1 M (-0.31 %) |
Jun 21 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.91 | 5,500 | 5,005 | 1,129,368 | 1.1 M to 1.1 M (-0.48 %) |
Jun 21 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.92 | 700 | 644 | 1,134,868 | 1.1 M to 1.1 M (-0.06 %) |
Jun 21 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.94 | 2,800 | 2,632 | 1,135,568 | 1.1 M to 1.1 M (-0.25 %) |
Jun 15 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.94 | 6,900 | 6,452 | 1,138,368 | 1.1 M to 1.1 M (-0.60 %) |
Jun 15 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.94 | 5,600 | 5,264 | 1,145,268 | 1.2 M to 1.1 M (-0.49 %) |
Jun 13 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.94 | 4,700 | 4,395 | 1,150,868 | 1.2 M to 1.2 M (-0.41 %) |
Jun 13 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.94 | 2,500 | 2,338 | 1,155,568 | 1.2 M to 1.2 M (-0.22 %) |
Jun 13 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.95 | 2,500 | 2,363 | 1,158,068 | 1.2 M to 1.2 M (-0.22 %) |
Jun 13 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.95 | 1,800 | 1,710 | 1,160,568 | 1.2 M to 1.2 M (-0.15 %) |
Jun 13 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.96 | 1,000 | 960 | 1,162,368 | 1.2 M to 1.2 M (-0.09 %) |
Jun 02 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.97 | 12,500 | 12,125 | 1,163,368 | 1.2 M to 1.2 M (-1.06 %) |
Jun 09 2011 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Option Exercise | A | 0.98 | 22,500 | 22,050 | 22,500 | |
Jun 09 2011 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Option Exercise | J | 0.65 | 384,663 | 250,031 | 384,663 | |
Jun 09 2011 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Option Exercise | J | 0.65 | 33,330 | 21,665 | 0 |